Particles in Hospira’s paclitaxel prompt Health Canada warning
Health Canada has warned of paclitaxel batches from Hospira that may have particles embedded in the vial or floating in the solution.
Archives for June 26, 2012
Repackager gets FDA warning for mislabelling drug strength
The FDA has sent contract repackager Shamrock Medical a warning letter for labelling drugs with the wrong strength.
UPDATE
UPDATES from DIA 2012: "Collaborate to innovate," says the association
“Collaborate to innovate,” is the message DIA has for clinical researchers at its 2012 Annual Meeting in Philadelphia, US.
EXCLUSIVE
Pakistan's re-joined health ministry still troubled, says PPMA
PPMA is fearful that the Government of Pakistan’s recent call for more foreign investment in the local pharma sector will go unheard because the industry is already overcrowded.
Round up of drug delivery news from academia
in-PharmaTechnologist.com presents a roundup of academic drug delivery news, including Pfizer working with Chinese researchers.
US base will bridge gap for manufacturing in China, says Suzhou pharma
China-based Suzhou Pharma has set up a US regulatory and QA hub in what it says is a bid to provide Western cGMP (current good manufacturing practice) know-how with low cost Asian production.